Evidence map›Paper›PMID 29269192›Full record

ReviewInfectious disease clinics of North America2018

New Developments in Rapid Diagnostic Testing for Children.

Mark D Gonzalez, Erin McElvania

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Respiratory syncytial virus: A new era.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Review
  4. RT-RPA-Frontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Impact of cerebrospinal fluid syndromic testing in the management of children with suspected central nervous system infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark D GonzalezDepartment of Pathology, Children's Healthcare of Atlanta, 1405 Clifton Road, Northeast, Atlanta, GA 30322, USA.
Erin McElvaniaDepartment of Pathology, NorthShore University Health System, 2650 Ridge Avenue, Evanston, IL 60201, USA. Electronic address: emcelvania@northshore.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of new diagnostics assays for Group A Streptococcus, influenza, and respiratory syncytial virus now provide rapid results with increased sensitivity and specificity. Molecular testing is no longer confined to the walls of the laboratory, but moving to the patient in the form of point-of-care tests. In addition, multiplex syndromic panels are allowing broad testing of pathogens associated with a single clinical presentation. This article focuses specifically on rapid diagnostic tests for pathogens most affecting children. Rapid and accurate pathogen detection in children may result in decreased time to optimal antimicrobial treatment and improved patient outcomes.

Indexed as

AdolescentChildChild, PreschoolCommunicable DiseasesDiagnostic Tests, RoutineHumansInfluenza, HumanMolecular Diagnostic TechniquesPoint-of-Care TestingSensitivity and SpecificityStreptococcal InfectionsGastrointestinal panelGroup A streptococcusInfluenzaMeningitis encephalitis panelRapid diagnostic assaysRespiratory panelRSVSyndromic multiplex panels

Identifiers

PMID29269192
PMCPMC7135313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.